CompletedNCT04828226
Clonidine to prevent confusion after electroconvulsive therapy
About this title
Read the official source — NCT04828226Medication studyAges 18+SwitzerlandDepression
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- BernSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: April 27, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 130
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Switzerland
- Age range
- Over 18 Years
- Official registry ID
- NCT04828226
- Official title
Show the full official title
Clonidine to Prevent Postictal Delirium After ElectroConvulsive Therapy: a Randomised, Placebo-controlled, Triple-blind, Single-centre Trial.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bern
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Insel Gruppe AG, University Hospital Bern, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Clonidine and Placebo.
Who was this study for?
Listed age limits: from 18 years.
